Today in News History

On July 12, several notable moments in the history of News stand out. In 1917, Andrew Wyeth, American artist (died 2009) was born. In 1923, James E. Gunn, American science fiction author (died 2020) was born. In 1943, Paul Silas, American basketball player and coach (died 2022) was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1971, Yvon Robert, Canadian wrestler (born 1914) passed away. In 1985, Keven Lacombe, Canadian cyclist was born. In 1995, Jordyn Wieber, American gymnast was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2010, James P. Hogan, English-American author (born 1941) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

Gizmodo

Gizmodo

·

July 8, 2026

·

left
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15 of Americans have ever taken the drugs, up from 6 in 2024.

Narrative Intelligence Brief

This article was published by Gizmodo, a source frequently categorized with a left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Gizmodo, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 17%

Center 33%

Right 33%


Foreign Policy Journal

left

· Jul 9, 2026

GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds

A new Gallup survey reveals that 11 of U.S. adults currently take GLP-1 medications for weight loss, a sharp rise from just 3 in 2024. The figure climbed steadily, moving from 3 in 2024 to 8 in 2025, before reaching the current 11 recorded in the latest survey conducted in mid-2026. Gallup also found that [] The post GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds appeared first on Foreign Policy Journal.

The Hill

center

· Jul 7, 2026

Number of Americans taking GLP-1s for weight loss hits record high: Survey

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. In addition, 15 percent...

NaturalNews.com

right

· Jul 9, 2026

GLP-1 Use Reaches Record High as Access Broadens, New Data Shows

(NaturalNews) The share of Americans using glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss has surged to unprecedented levels, according to report...

WRAL News

center

· Jul 1, 2026

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans.

Scientific American

Unknown

· Jun 25, 2026

Weight loss drugs don't work for everyone—here’s why

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why may be genetics

Knewz

lean right

· Jul 6, 2026

Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!

Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...

Topics:

World · 2
Unknown · 1
Politics · 1
Health · 1
Science · 1

Related coverage for "11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy": Foreign Policy Journal — GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds. The Hill — Number of Americans taking GLP-1s for weight loss hits record high: Survey. NaturalNews.com — GLP-1 Use Reaches Record High as Access Broadens, New Data Shows. WRAL News — Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know. Scientific American — Weight loss drugs don't work for everyone—here’s why. Knewz — Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!